Copyright Reports & Markets. All rights reserved.

Global Cellular Therapy (CT) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cellular Therapy (CT)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cellular Therapy (CT) by Type
    • 1.3.1 Overview: Global Cellular Therapy (CT) Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cellular Therapy (CT) Consumption Value Market Share by Type in 2023
    • 1.3.3 Stem Cell
    • 1.3.4 Non-Stem Cell
  • 1.4 Global Cellular Therapy (CT) Market by Application
    • 1.4.1 Overview: Global Cellular Therapy (CT) Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Cellular Therapy (CT) Market Size & Forecast
  • 1.6 Global Cellular Therapy (CT) Market Size and Forecast by Region
    • 1.6.1 Global Cellular Therapy (CT) Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cellular Therapy (CT) Market Size by Region, (2019-2030)
    • 1.6.3 North America Cellular Therapy (CT) Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cellular Therapy (CT) Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cellular Therapy (CT) Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cellular Therapy (CT) Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cellular Therapy (CT) Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Gilead Sciences
    • 2.1.1 Gilead Sciences Details
    • 2.1.2 Gilead Sciences Major Business
    • 2.1.3 Gilead Sciences Cellular Therapy (CT) Product and Solutions
    • 2.1.4 Gilead Sciences Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Gilead Sciences Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Cellular Therapy (CT) Product and Solutions
    • 2.2.4 Novartis Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Osiris
    • 2.3.1 Osiris Details
    • 2.3.2 Osiris Major Business
    • 2.3.3 Osiris Cellular Therapy (CT) Product and Solutions
    • 2.3.4 Osiris Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Osiris Recent Developments and Future Plans
  • 2.4 Vericel Corporation
    • 2.4.1 Vericel Corporation Details
    • 2.4.2 Vericel Corporation Major Business
    • 2.4.3 Vericel Corporation Cellular Therapy (CT) Product and Solutions
    • 2.4.4 Vericel Corporation Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Vericel Corporation Recent Developments and Future Plans
  • 2.5 Vcanbio
    • 2.5.1 Vcanbio Details
    • 2.5.2 Vcanbio Major Business
    • 2.5.3 Vcanbio Cellular Therapy (CT) Product and Solutions
    • 2.5.4 Vcanbio Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Vcanbio Recent Developments and Future Plans
  • 2.6 Fujifilm Cellular Dynamics
    • 2.6.1 Fujifilm Cellular Dynamics Details
    • 2.6.2 Fujifilm Cellular Dynamics Major Business
    • 2.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Product and Solutions
    • 2.6.4 Fujifilm Cellular Dynamics Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Fujifilm Cellular Dynamics Recent Developments and Future Plans
  • 2.7 JCR Pharmaceuticals
    • 2.7.1 JCR Pharmaceuticals Details
    • 2.7.2 JCR Pharmaceuticals Major Business
    • 2.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Product and Solutions
    • 2.7.4 JCR Pharmaceuticals Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 JCR Pharmaceuticals Recent Developments and Future Plans
  • 2.8 Beike Biotechnology
    • 2.8.1 Beike Biotechnology Details
    • 2.8.2 Beike Biotechnology Major Business
    • 2.8.3 Beike Biotechnology Cellular Therapy (CT) Product and Solutions
    • 2.8.4 Beike Biotechnology Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Beike Biotechnology Recent Developments and Future Plans
  • 2.9 Golden Meditech
    • 2.9.1 Golden Meditech Details
    • 2.9.2 Golden Meditech Major Business
    • 2.9.3 Golden Meditech Cellular Therapy (CT) Product and Solutions
    • 2.9.4 Golden Meditech Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Golden Meditech Recent Developments and Future Plans
  • 2.10 Guanhao Biotech
    • 2.10.1 Guanhao Biotech Details
    • 2.10.2 Guanhao Biotech Major Business
    • 2.10.3 Guanhao Biotech Cellular Therapy (CT) Product and Solutions
    • 2.10.4 Guanhao Biotech Cellular Therapy (CT) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Guanhao Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cellular Therapy (CT) Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cellular Therapy (CT) by Company Revenue
    • 3.2.2 Top 3 Cellular Therapy (CT) Players Market Share in 2023
    • 3.2.3 Top 6 Cellular Therapy (CT) Players Market Share in 2023
  • 3.3 Cellular Therapy (CT) Market: Overall Company Footprint Analysis
    • 3.3.1 Cellular Therapy (CT) Market: Region Footprint
    • 3.3.2 Cellular Therapy (CT) Market: Company Product Type Footprint
    • 3.3.3 Cellular Therapy (CT) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cellular Therapy (CT) Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cellular Therapy (CT) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cellular Therapy (CT) Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cellular Therapy (CT) Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cellular Therapy (CT) Consumption Value by Type (2019-2030)
  • 6.2 North America Cellular Therapy (CT) Consumption Value by Application (2019-2030)
  • 6.3 North America Cellular Therapy (CT) Market Size by Country
    • 6.3.1 North America Cellular Therapy (CT) Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cellular Therapy (CT) Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cellular Therapy (CT) Consumption Value by Type (2019-2030)
  • 7.2 Europe Cellular Therapy (CT) Consumption Value by Application (2019-2030)
  • 7.3 Europe Cellular Therapy (CT) Market Size by Country
    • 7.3.1 Europe Cellular Therapy (CT) Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 7.3.3 France Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cellular Therapy (CT) Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cellular Therapy (CT) Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cellular Therapy (CT) Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Region
    • 8.3.1 Asia-Pacific Cellular Therapy (CT) Consumption Value by Region (2019-2030)
    • 8.3.2 China Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 8.3.5 India Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cellular Therapy (CT) Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cellular Therapy (CT) Consumption Value by Type (2019-2030)
  • 9.2 South America Cellular Therapy (CT) Consumption Value by Application (2019-2030)
  • 9.3 South America Cellular Therapy (CT) Market Size by Country
    • 9.3.1 South America Cellular Therapy (CT) Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cellular Therapy (CT) Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cellular Therapy (CT) Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cellular Therapy (CT) Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Country
    • 10.3.1 Middle East & Africa Cellular Therapy (CT) Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cellular Therapy (CT) Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cellular Therapy (CT) Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cellular Therapy (CT) Market Drivers
  • 11.2 Cellular Therapy (CT) Market Restraints
  • 11.3 Cellular Therapy (CT) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cellular Therapy (CT) Industry Chain
  • 12.2 Cellular Therapy (CT) Upstream Analysis
  • 12.3 Cellular Therapy (CT) Midstream Analysis
  • 12.4 Cellular Therapy (CT) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cellular Therapy (CT) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Cellular Therapy (CT) industry chain, the market status of Hospitals (Stem Cell, Non-Stem Cell), Clinics (Stem Cell, Non-Stem Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cellular Therapy (CT).
    Regionally, the report analyzes the Cellular Therapy (CT) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cellular Therapy (CT) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cellular Therapy (CT) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cellular Therapy (CT) industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Stem Cell, Non-Stem Cell).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cellular Therapy (CT) market.
    Regional Analysis: The report involves examining the Cellular Therapy (CT) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cellular Therapy (CT) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cellular Therapy (CT):
    Company Analysis: Report covers individual Cellular Therapy (CT) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cellular Therapy (CT) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
    Technology Analysis: Report covers specific technologies relevant to Cellular Therapy (CT). It assesses the current state, advancements, and potential future developments in Cellular Therapy (CT) areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cellular Therapy (CT) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cellular Therapy (CT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Stem Cell
    Non-Stem Cell
    Market segment by Application
    Hospitals
    Clinics
    Others
    Market segment by players, this report covers
    Gilead Sciences
    Novartis
    Osiris
    Vericel Corporation
    Vcanbio
    Fujifilm Cellular Dynamics
    JCR Pharmaceuticals
    Beike Biotechnology
    Golden Meditech
    Guanhao Biotech
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cellular Therapy (CT) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cellular Therapy (CT), with revenue, gross margin and global market share of Cellular Therapy (CT) from 2019 to 2024.
    Chapter 3, the Cellular Therapy (CT) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cellular Therapy (CT) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cellular Therapy (CT).
    Chapter 13, to describe Cellular Therapy (CT) research findings and conclusion.

    Buy now